Yvette leads corporate development at Dyno Therapeutics, where she oversees business development, commercial strategy, alliance management, and external communications. Prior to joining Dyno, Yvette served as a commercial brand lead at Celgene (now Bristol-Myers Squibb), where she successfully led the US launch of multiple hematology brands. Prior to Celgene, Yvette was a strategy consultant at L.E.K. Consulting and a researcher at McLean Hospital focusing on neuroregeneration in Parkinson's disease. Yvette holds an MBA in Health Care Management from The Wharton School and a BA in Chemical and Physical Biology from Harvard.